By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck KGaA 

Frankfurter Street 250

Darmstadt    D-64293  Germany
Phone: 49-6151-720 Fax: 49-6151-722000




SmithKline Beecham 

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in diabetes and obesity.

GlaxoSmithKline (North Carolina) 

TargeGen, Inc.  Licensing Agreement - Vascular Biology Portfolio.

Company News
Merck KGaA (MKGAF.PK), Darmstadt, Germany Welcomes ZEISS And Hamilton Thorne As New Members Of The Global Fertility Alliance 6/30/2016 10:57:59 AM
What Happens to Merck KGaA (MKGAF.PK) Jobs After the UK Voted Brexit 6/24/2016 7:46:56 AM
Array BioPharma (ARRY), Pierre Fabre And Merck KGaA (MKGAF.PK), Darmstadt, Germany Announce Phase 3 BEACON CRC Trial 6/6/2016 10:58:54 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) To Present Avelumab Data In Seven Different Cancers At ASCO Annual Meeting 5/19/2016 9:40:35 AM
Merck KGaA (MKGAF.PK) Release: Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone 4/25/2016 6:36:34 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany Supports Next Generation Of Scientists At USA Science & Engineering Festival 4/14/2016 9:51:30 AM
R-Biopharm AG And Merck KGaA (MKGAF.PK), Darmstadt, Germany Enter Into Collaboration On Developing And Launching Companion Diagnostics 3/22/2016 9:33:58 AM
BioMed X Innovation Center And Merck KGaA (MKGAF.PK) Extend Collaboration In Cancer Research 3/3/2016 8:35:54 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany Initiates Phase III Study Of MSB11022, A Proposed Biosimilar Of Adalimumab, In Chronic Plaque Psoriasis 3/2/2016 6:05:00 AM
Threshold Pharma (THLD) And Merck KGaA (MKGAF.PK), Darmstadt, Germany Agree To Key Terms For The Licensing Back Of All Rights To Evofosfamide To Threshold 1/12/2016 12:32:33 PM